Nurix Therapeutics Inc
NASDAQ:NRIX
Nurix Therapeutics Inc
NASDAQ:NRIX
Price:
15.04
USD
-3.65%
Market Closed
Market Cap:
$1.5B
Cash Flow Statement
Cash Flow Statement
Nurix Therapeutics Inc
Nurix Therapeutics Inc
Currency: USD
| Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||
| Net Income |
(22)
|
(31)
|
(21)
|
(37)
|
(43)
|
(55)
|
(89)
|
(99)
|
(117)
|
(135)
|
(154)
|
(171)
|
(180)
|
(179)
|
(157)
|
(149)
|
(144)
|
(145)
|
(165)
|
(177)
|
(194)
|
(208)
|
(207)
|
(245)
|
(264)
|
|
| Depreciation & Amortization |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
5
|
6
|
7
|
7
|
8
|
8
|
12
|
14
|
9
|
10
|
6
|
4
|
9
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
2
|
4
|
7
|
10
|
13
|
16
|
19
|
22
|
25
|
28
|
31
|
32
|
34
|
34
|
33
|
33
|
33
|
34
|
35
|
36
|
37
|
38
|
|
| Other Non-Cash Items |
0
|
1
|
1
|
2
|
5
|
7
|
11
|
15
|
21
|
26
|
30
|
34
|
34
|
36
|
36
|
36
|
35
|
34
|
29
|
26
|
30
|
29
|
35
|
40
|
38
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
20
|
80
|
68
|
40
|
36
|
12
|
25
|
8
|
9
|
(29)
|
(16)
|
(20)
|
(19)
|
(29)
|
(36)
|
(41)
|
20
|
29
|
28
|
40
|
(18)
|
(22)
|
(49)
|
(30)
|
(32)
|
|
| Cash from Operating Activities |
1
N/A
|
51
+8 442%
|
50
-2%
|
8
-85%
|
(0)
N/A
|
(33)
-41 150%
|
(50)
-52%
|
(74)
-48%
|
(84)
-14%
|
(135)
-60%
|
(136)
-1%
|
(153)
-12%
|
(160)
-5%
|
(166)
-4%
|
(151)
+9%
|
(146)
+3%
|
(81)
+44%
|
(75)
+8%
|
(96)
-28%
|
(97)
-1%
|
(173)
-78%
|
(192)
-11%
|
(215)
-12%
|
(230)
-7%
|
(249)
-8%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(3)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(8)
|
(9)
|
(11)
|
(12)
|
(11)
|
(9)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(9)
|
(10)
|
(11)
|
(11)
|
(14)
|
|
| Other Items |
10
|
(8)
|
(19)
|
(130)
|
(250)
|
(232)
|
(287)
|
(191)
|
(103)
|
(58)
|
(5)
|
(54)
|
39
|
14
|
61
|
146
|
77
|
97
|
(77)
|
(122)
|
(248)
|
(258)
|
(55)
|
18
|
162
|
|
| Cash from Investing Activities |
9
N/A
|
(10)
N/A
|
(23)
-119%
|
(134)
-493%
|
(254)
-90%
|
(237)
+7%
|
(292)
-23%
|
(196)
+33%
|
(108)
+45%
|
(66)
+39%
|
(13)
+80%
|
(64)
-377%
|
27
N/A
|
3
-88%
|
52
+1 500%
|
138
+166%
|
68
-50%
|
88
+28%
|
(87)
N/A
|
(131)
-51%
|
(258)
-96%
|
(268)
-4%
|
(65)
+76%
|
7
N/A
|
148
+2 110%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
120
|
340
|
339
|
340
|
371
|
152
|
154
|
154
|
4
|
118
|
117
|
117
|
117
|
3
|
3
|
3
|
241
|
285
|
486
|
486
|
248
|
203
|
239
|
|
| Other |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
0
+31%
|
120
+70 376%
|
340
+184%
|
339
0%
|
340
+0%
|
371
+9%
|
152
-59%
|
154
+1%
|
154
+0%
|
4
-97%
|
118
+2 868%
|
117
-1%
|
117
0%
|
117
0%
|
3
-97%
|
3
+5%
|
3
+4%
|
241
+7 073%
|
285
+18%
|
486
+70%
|
486
0%
|
248
-49%
|
203
-18%
|
239
+17%
|
|
| Change in Cash | ||||||||||||||||||||||||||
| Net Change in Cash |
9
N/A
|
41
+345%
|
147
+259%
|
214
+45%
|
85
-60%
|
70
-17%
|
29
-59%
|
(118)
N/A
|
(39)
+67%
|
(47)
-21%
|
(146)
-211%
|
(99)
+32%
|
(15)
+84%
|
(45)
-193%
|
17
N/A
|
(5)
N/A
|
(10)
-87%
|
16
N/A
|
58
+256%
|
57
-2%
|
55
-2%
|
26
-53%
|
(33)
N/A
|
(21)
+37%
|
137
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
49
N/A
|
47
-5%
|
3
-93%
|
(5)
N/A
|
(38)
-721%
|
(56)
-46%
|
(80)
-43%
|
(90)
-13%
|
(143)
-59%
|
(145)
-1%
|
(163)
-12%
|
(172)
-5%
|
(177)
-3%
|
(161)
+9%
|
(154)
+4%
|
(90)
+42%
|
(84)
+7%
|
(106)
-26%
|
(107)
-1%
|
(182)
-70%
|
(202)
-11%
|
(226)
-12%
|
(241)
-7%
|
(263)
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
